End-of-day quote
Shanghai S.E.
23:00:00 27/06/2024 BST
|
5-day change
|
1st Jan Change
|
3.48
CNY
|
+0.58%
|
|
-0.29%
|
-17.34%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,901
|
15,289
|
10,521
|
8,507
|
6,962
|
-
|
-
|
Enterprise Value (EV)
1 |
7,901
|
15,289
|
10,521
|
8,507
|
6,962
|
6,962
|
6,962
|
P/E ratio
|
15.4
x
|
8.39
x
|
8.86
x
|
22.2
x
|
17.4
x
|
12.9
x
|
7.73
x
|
Yield
|
-
|
1.88%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
1.65
x
|
-
|
-
|
0.61
x
|
0.57
x
|
0.51
x
|
EV / Revenue
|
-
|
1.65
x
|
-
|
-
|
0.61
x
|
0.57
x
|
0.51
x
|
EV / EBITDA
|
-
|
5.66
x
|
-
|
-
|
3.36
x
|
3.03
x
|
2.46
x
|
EV / FCF
|
-
|
1,199,823,905
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.57
x
|
-
|
-
|
0.61
x
|
0.58
x
|
0.54
x
|
Nbr of stocks (in thousands)
|
1,505,000
|
1,918,378
|
2,046,953
|
2,020,563
|
2,000,594
|
-
|
-
|
Reference price
2 |
5.250
|
7.970
|
5.140
|
4.210
|
3.480
|
3.480
|
3.480
|
Announcement Date
|
05/02/21
|
28/02/22
|
17/02/23
|
26/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
9,268
|
-
|
-
|
11,344
|
12,154
|
13,594
|
EBITDA
1 |
-
|
2,701
|
-
|
-
|
2,074
|
2,296
|
2,834
|
EBIT
1 |
-
|
2,218
|
-
|
-
|
558
|
738
|
1,235
|
Operating Margin
|
-
|
23.93%
|
-
|
-
|
4.92%
|
6.07%
|
9.08%
|
Earnings before Tax (EBT)
1 |
-
|
2,203
|
-
|
-
|
553
|
733
|
1,230
|
Net income
1 |
512.2
|
1,626
|
1,170
|
383.1
|
420
|
557
|
935
|
Net margin
|
-
|
17.54%
|
-
|
-
|
3.7%
|
4.58%
|
6.88%
|
EPS
2 |
0.3400
|
0.9500
|
0.5800
|
0.1900
|
0.2000
|
0.2700
|
0.4500
|
Free Cash Flow
|
-
|
12.74
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
0.14%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
0.47%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
0.78%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.1500
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
05/02/21
|
28/02/22
|
17/02/23
|
26/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
12.7
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
18.5%
|
-
|
-
|
3.6%
|
4.5%
|
7%
|
ROA (Net income/ Total Assets)
|
-
|
10.4%
|
-
|
-
|
1.8%
|
2.4%
|
3.7%
|
Assets
1 |
-
|
15,571
|
-
|
-
|
23,333
|
23,208
|
25,270
|
Book Value Per Share
2 |
-
|
5.080
|
-
|
-
|
5.750
|
6.020
|
6.470
|
Cash Flow per Share
2 |
-
|
1.160
|
-
|
-
|
1.240
|
0.7600
|
1.270
|
Capex
1 |
-
|
2,317
|
-
|
-
|
1,104
|
1,104
|
1,104
|
Capex / Sales
|
-
|
25%
|
-
|
-
|
9.73%
|
9.08%
|
8.12%
|
Announcement Date
|
05/02/21
|
28/02/22
|
17/02/23
|
26/04/24
|
-
|
-
|
-
|
Last Close Price
3.48
CNY Average target price
7.47
CNY Spread / Average Target +114.66% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.34% | 958M | | +0.73% | 99.64B | | -11.98% | 58.77B | | +75.71% | 48.81B | | +5.26% | 34.94B | | +0.61% | 31.15B | | +3.47% | 18.62B | | +17.33% | 17.44B | | +5.92% | 13.51B | | -6.67% | 12.73B |
Other Commodity Chemicals
|